Matthew M. Ames
Impact in
- Pharmacology top 0.1%
- Pharmacogenetics and Drug Metabolism
- Oncology top 1%
- Cancer Treatment and Pharmacology
Papers in
-
- Cancer therapeutics and mechanisms 40
- Histone Deacetylase Inhibitors Research 15
- Oncology 63
- Cancer Treatment and Pharmacology 19
- Co-authors
- Joel M. Reid (104 shared papers)Matthew P. Goetz (37 shared papers)Stephanie L. Safgren (38 shared papers)Charles Erlichman (27 shared papers)Mary J. Kuffel (25 shared papers)Joseph Rubin (8 shared papers)Vera J. Suman (16 shared papers)James N. Ingle (16 shared papers)
- Journals
- Journal of Clinical Oncology (33 papers)Cancer Chemotherapy and Pharmacology (17 papers)Clinical Cancer Research (13 papers)Investigational New Drugs (10 papers)Cancer Research (7 papers)
- Partner nations
- United StatesJapanUnited Kingdom
In The Last Decade
Matthew M. Ames
234 papers receiving 9.4k citations
Matthew M. Ames's Hit Papers
Peers
Comparison fields: 5 of 162
- Pharmacology 1.3k
- Oncology 2.3k
- Genetics 716
- Cancer Research 904
- Molecular Biology 3.9k
Countries citing papers authored by Matthew M. Ames
This map shows the geographic impact of Matthew M. Ames's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew M. Ames with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew M. Ames more than expected).
Fields of papers citing papers by Matthew M. Ames
This network shows the impact of papers produced by Matthew M. Ames. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew M. Ames. The network helps show where Matthew M. Ames may publish in the future.
Co-authors
The 25 scholars most cited alongside Matthew M. Ames, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 239 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Pharmacogenetics of Tamoxifen Biotransformation Is Associated With Clinical Outcomes of Efficacy and Hot Flashes Hit paper breakdown → | 2005 | 607 |
| 2 | High-Dose Vitamin C versus Placebo in the Treatment of Patients with Advanced Cancer Who Have Had No Prior Chemotherapy Hit paper breakdown → | 1985 | 488 |
| 3 | 2006 | 422 | |
| 4 | 2008 | 321 | |
| 5 | 2009 | 301 | |
| 6 | 2003 | 282 | |
| 7 | 2005 | 282 | |
| 8 | 2013 | 225 | |
| 9 | 1985 | 225 | |
| 10 | 2010 | 159 | |
| 11 | 1975 | 156 | |
| 12 | 1977 | 149 | |
| 13 | 1990 | 148 | |
| 14 | 2007 | 141 | |
| 15 | 2008 | 141 | |
| 16 | 2006 | 137 | |
| 17 | 2006 | 122 | |
| 18 | 1978 | 119 | |
| 19 | Metabolic activation of dacarbazine by human cytochromes P450: the role of CYP1A1, CYP1A2, and CYP2E1. | 1999 | 112 |
| 20 | 2007 | 109 |
About Matthew M. Ames
Matthew M. Ames is a scholar working on Molecular Biology, Oncology, Pharmacology, Pulmonary and Respiratory Medicine and Organic Chemistry, having authored 239 papers that have together received 9.9k indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (40 papers), Pharmacogenetics and Drug Metabolism (25 papers), Cancer Treatment and Pharmacology (19 papers), Histone Deacetylase Inhibitors Research (15 papers), Estrogen and related hormone effects (15 papers), Glioma Diagnosis and Treatment (12 papers), Acute Lymphoblastic Leukemia research (11 papers) and Lung Cancer Treatments and Mutations (9 papers). The work is most often cited by research in Pharmacology (1.3k citations), Oncology (2.3k citations), Genetics (716 citations), Cancer Research (904 citations) and Molecular Biology (3.9k citations). Matthew M. Ames has collaborated with scholars based in United States, Japan and United Kingdom. Frequent co-authors include Joel M. Reid, Matthew P. Goetz, Stephanie L. Safgren, Charles Erlichman, Mary J. Kuffel, Joseph Rubin, Vera J. Suman, James N. Ingle, Mark Krailo and Edward T. Creagan. Their work appears in journals such as Journal of Clinical Oncology, Cancer Chemotherapy and Pharmacology, Clinical Cancer Research, Investigational New Drugs and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.